France's Sanofi to seek vaccine nod after delays

Paris: French pharmaceuticals giant Sanofi said on Wednesday that its Covid-19 vaccine, developed with Britain's GSK, had delivered positive results after a year of delays left it lagging behind rivals. The two drugmakers said they will "seek regulatory authorisation" for their vaccine in US and the EU following phase 3 trials involving thousands of people. The trials indicated the vaccine was 100% effective against severe Covid and hospitalisation, Sanofi said in a statement. It was also more than 50% effective against all symptomatic Covid, the statement added.